BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bakouny Z, Choueiri TK. IL-8 and cancer prognosis on immunotherapy. Nat Med 2020;26:650-1. [PMID: 32405061 DOI: 10.1038/s41591-020-0873-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Lonie JM, Barbour AP, Dolcetti R. Understanding the immuno-biology of oesophageal adenocarcinoma: Towards improved therapeutic approaches. Cancer Treat Rev 2021;98:102219. [PMID: 33993033 DOI: 10.1016/j.ctrv.2021.102219] [Reference Citation Analysis]
2 Nguyen OTP, Misun PM, Lohasz C, Lee J, Wang W, Schroeder T, Hierlemann A. An Immunocompetent Microphysiological System to Simultaneously Investigate Effects of Anti-Tumor Natural Killer Cells on Tumor and Cardiac Microtissues. Front Immunol 2021;12:781337. [PMID: 34925361 DOI: 10.3389/fimmu.2021.781337] [Reference Citation Analysis]
3 An HJ, Chon HJ, Kim C. Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors. Int J Mol Sci 2021;22:9414. [PMID: 34502325 DOI: 10.3390/ijms22179414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chehrazi-Raffle A, Meza L, Alcantara M, Dizman N, Bergerot P, Salgia N, Hsu J, Ruel N, Salgia S, Malhotra J, Karczewska E, Kortylewski M, Pal S. Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma. J Immunother Cancer 2021;9:e002009. [PMID: 33688021 DOI: 10.1136/jitc-2020-002009] [Reference Citation Analysis]
5 Braun DA, Bakouny Z, Hirsch L, Flippot R, Van Allen EM, Wu CJ, Choueiri TK. Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. Nat Rev Clin Oncol 2021;18:199-214. [PMID: 33437048 DOI: 10.1038/s41571-020-00455-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
6 Gkika E, Adebahr S, Brenner A, Schimek-Jasch T, Radicioni G, Exner JP, Rühle A, Spohn SKB, Popp I, Zamboglou C, Sprave T, Firat E, Niedermann G, Nicolay NH, Nestle U, Grosu AL, Duda DG. Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies. Cancers (Basel) 2021;13:5725. [PMID: 34830880 DOI: 10.3390/cancers13225725] [Reference Citation Analysis]
7 Carlsen L, Schorl C, Huntington K, Hernandez-Borrero L, Jhaveri A, Zhang S, Zhou L, El-Deiry WS. Pan-drug and drug-specific mechanisms of 5-FU, irinotecan (CPT-11), oxaliplatin, and cisplatin identified by comparison of transcriptomic and cytokine responses of colorectal cancer cells. Oncotarget 2021;12:2006-21. [PMID: 34611476 DOI: 10.18632/oncotarget.28075] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Díaz-Carballo D, Saka S, Acikelli AH, Homp E, Erwes J, Demmig R, Klein J, Schröer K, Malak S, D'Souza F, Noa-Bolaño A, Menze S, Pano E, Andrioff S, Teipel M, Dammann P, Klein D, Nasreen A, Tannapfel A, Grandi N, Tramontano E, Ochsenfarth C, Strumberg D. Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors. Commun Biol 2021;4:276. [PMID: 33658617 DOI: 10.1038/s42003-021-01800-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Marin-Acevedo JA, Kimbrough EO, Lou Y. Next generation of immune checkpoint inhibitors and beyond. J Hematol Oncol 2021;14:45. [PMID: 33741032 DOI: 10.1186/s13045-021-01056-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
10 Knoche SM, Larson AC, Sliker BH, Poelaert BJ, Solheim JC. The role of tumor heterogeneity in immune-tumor interactions. Cancer Metastasis Rev 2021;40:377-89. [PMID: 33682030 DOI: 10.1007/s10555-021-09957-3] [Reference Citation Analysis]
11 Briukhovetska D, Dörr J, Endres S, Libby P, Dinarello CA, Kobold S. Interleukins in cancer: from biology to therapy. Nat Rev Cancer 2021;21:481-99. [PMID: 34083781 DOI: 10.1038/s41568-021-00363-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
12 Li X, Shi H, Zhang W, Bai C, He M, Ta N, Huang H, Ning Y, Fang C, Qin H, Dong Y. Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma. Front Oncol 2021;11:690115. [PMID: 34660264 DOI: 10.3389/fonc.2021.690115] [Reference Citation Analysis]
13 Xiong X, Liao X, Qiu S, Xu H, Zhang S, Wang S, Ai J, Yang L. CXCL8 in Tumor Biology and Its Implications for Clinical Translation. Front Mol Biosci 2022;9:723846. [DOI: 10.3389/fmolb.2022.723846] [Reference Citation Analysis]
14 Arvanitakis K, Mitroulis I, Germanidis G. Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy. Cancers (Basel) 2021;13:2899. [PMID: 34200529 DOI: 10.3390/cancers13122899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Rice SJ, Belani CP. Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer. PLoS One 2021;16:e0260988. [PMID: 34855926 DOI: 10.1371/journal.pone.0260988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Abdel-Azim H, Dave H, Jordan K, Rawlings-Rhea S, Luong A, Wilson AL. Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy. Cytotherapy 2021:S1465-3249(21)00783-0. [PMID: 34711500 DOI: 10.1016/j.jcyt.2021.08.007] [Reference Citation Analysis]
17 Huang Y, Yang X, Meng Y, Shao C, Liao J, Li F, Li R, Jing Y, Huang A. The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages. Cell Biosci 2021;11:173. [PMID: 34530917 DOI: 10.1186/s13578-021-00683-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chen IM, Johansen JS, Theile S, Hjaltelin JX, Novitski SI, Brunak S, Hasselby JP, Willemoe GL, Lorentzen T, Madsen K, Jensen BV, Wilken EE, Geertsen P, Behrens C, Nolsoe C, Hermann KL, Svane IM, Nielsen D. Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC). J Clin Oncol 2022;:JCO2102511. [PMID: 35476508 DOI: 10.1200/JCO.21.02511] [Reference Citation Analysis]
19 Tsai YT, Strauss J, Toney NJ, Jochems C, Venzon DJ, Gulley JL, Schlom J, Donahue RN. Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa. J Immunother Cancer 2022;10:e004601. [PMID: 35418484 DOI: 10.1136/jitc-2022-004601] [Reference Citation Analysis]
20 Furqan M, Abu-hejleh T, Stephens LM, Hartwig SM, Mott SL, Pulliam CF, Petronek M, Henrich JB, Fath MA, Houtman JC, Varga SM, Bodeker KL, Bossler AD, Bellizzi AM, Zhang J, Monga V, Mani H, Ivanovic M, Smith BJ, Byrne MM, Zeitler W, Wagner BA, Buettner GR, Cullen JJ, Buatti JM, Spitz DR, Allen BG. Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102318] [Reference Citation Analysis]
21 Merlano MC, Abbona A, Paccagnella M, Falletta A, Granetto C, Ricci V, Fea E, Denaro N, Ruatta F, Merlotti A, Bertetto O, Crosetto N, Galizia D, Basiricò M, Gammaitoni L, Sangiolo D, Aglietta M, Garrone O. Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy. Vaccines (Basel) 2021;9:235. [PMID: 33800511 DOI: 10.3390/vaccines9030235] [Reference Citation Analysis]
22 Bullock K, Richmond A. Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy. Cancers (Basel) 2021;13:6293. [PMID: 34944914 DOI: 10.3390/cancers13246293] [Reference Citation Analysis]
23 Padmanabhan S, Gaire B, Zou Y, Uddin MM, DeLeon D, Vancurova I. IFNγ induces JAK1/STAT1/p65 NFκB-dependent interleukin-8 expression in ovarian cancer cells, resulting in their increased migration. Int J Biochem Cell Biol 2021;141:106093. [PMID: 34626802 DOI: 10.1016/j.biocel.2021.106093] [Reference Citation Analysis]
24 Zhang J, Pan Y, Shi Q, Zhang G, Jiang L, Dong X, Gu K, Wang H, Zhang X, Yang N, Li Y, Xiong J, Yi T, Peng M, Song Y, Fan Y, Cui J, Chen G, Tan W, Zang A, Guo Q, Zhao G, Wang Z, He J, Yao W, Wu X, Chen K, Hu X, Hu C, Yue L, Jiang D, Wang G, Liu J, Yu G, Li J, Bai J, Xie W, Zhao W, Wu L, Zhou C. Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study. Cancer Commun (Lond) 2021. [PMID: 34699693 DOI: 10.1002/cac2.12225] [Reference Citation Analysis]
25 Anderson R, Blidner AG, Rapoport BL. Frontiers in Pharmacology: Review Manuscript Targeting of the Neutrophil as an Adjunctive Strategy in Non-Small Cell Lung Cancer. Front Pharmacol 2021;12:676399. [PMID: 34168563 DOI: 10.3389/fphar.2021.676399] [Reference Citation Analysis]
26 Ramachandran S, Verma AK, Dev K, Goyal Y, Bhatt D, Alsahli MA, Rahmani AH, Almatroudi A, Almatroodi SA, Alrumaihi F, Khan NA. Role of Cytokines and Chemokines in NSCLC Immune Navigation and Proliferation. Oxid Med Cell Longev 2021;2021:5563746. [PMID: 34336101 DOI: 10.1155/2021/5563746] [Reference Citation Analysis]
27 Jędrzejewski T, Sobocińska J, Pawlikowska M, Dzialuk A, Wrotek S. Extract from the Coriolus versicolor Fungus as an Anti-Inflammatory Agent with Cytotoxic Properties against Endothelial Cells and Breast Cancer Cells. Int J Mol Sci 2020;21:E9063. [PMID: 33260615 DOI: 10.3390/ijms21239063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Mohsenzadegan M, Moghbeli F, Mirshafiey A, Farajollahi MM. Anti-tumor effect of M2000 (β-d-mannuronic acid) on the expression of inflammatory molecules in the prostate cancer cell. Immunopharmacol Immunotoxicol 2021;43:419-30. [PMID: 34057866 DOI: 10.1080/08923973.2021.1931301] [Reference Citation Analysis]
29 Fuschillo S, Battiloro C, Rocco D, D Gravara L, Motta A, Maniscalco M. Biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer. Biomark Med 2020;14:929-32. [PMID: 32940076 DOI: 10.2217/bmm-2020-0242] [Reference Citation Analysis]
30 Azzouzi S, Ben Ali M, Bellagambi F, Elaissari A, Jaffrezic-Renault N, Errachid A, Zine N. Spatially hierarchical nano-architecture for real time detection of Interleukin-8 cancer biomarker. Talanta 2022;246:123436. [PMID: 35489096 DOI: 10.1016/j.talanta.2022.123436] [Reference Citation Analysis]